Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Orthofix Medical Inc.OFIX · Entity 1975 | Director | June 06, 2022 | June 08, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Orthofix Medical Inc.
Report date June 06, 2022 · Filed June 08, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,615 |
Reported balance
After 2022-06-06 transaction · row 1
1 source rowRow 1 · 2022-06-06 · Grant · Acquired 6,383 · Balance 21,615 F1: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2022 Filed Jun 8, 2022 20:31 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 6,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035040 · doc4.xml · nonDerivative · entry 1 SICARD JOHN · CIK 0001734027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,615 F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:37 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 4,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-042751 · doc4.xml · nonDerivative · entry 1 SICARD JOHN · CIK 0001734027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,232 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 21, 2021. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:55 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 4,588 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035652 · doc4.xml · nonDerivative · entry 1 SICARD JOHN · CIK 0001734027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,919 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 8, 2020. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 22:03 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 3,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036920 · doc4.xml · nonDerivative · entry 1 SICARD JOHN · CIK 0001734027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,331 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 11, 2019. Read SEC document |
| July 17, 2018 Filed Jul 17, 2018 23:03 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 2,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-042924 · doc4.xml · nonDerivative · entry 1 SICARD JOHN · CIK 0001734027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,900 F1 · shares: Deferred Stock Unit award granted on July 2, 2018, subject to shareholder approval, which was obtained on July 17, 2018, and is subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These awards vest in full on July 2, 2019. Read SEC document |
| March 12, 2018 Filed Mar 13, 2018 20:19 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $59.49 | $0.00 |
DisclosureSEC source: 0001209191-18-019207 · doc4.xml · derivative · entry 1 SICARD JOHN · CIK 0001734027 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-03-12 F1 · derivative.exercise_date: These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, March 12, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.